Galderma Launches Sculptra in China
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
The device combines tumescent local anesthesia infiltration, power-assisted tissue removal, and aspiration into a single platform.